378 related articles for article (PubMed ID: 22322820)
1. Identification of drug-related problems in ambulatory chronic kidney disease patients: a 6-month prospective study.
Belaiche S; Romanet T; Allenet B; Calop J; Zaoui P
J Nephrol; 2012; 25(5):782-8. PubMed ID: 22322820
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical care in chronic kidney disease: experience at Grenoble University Hospital from 2006 to 2010.
Belaiche S; Romanet T; Bell R; Calop J; Allenet B; Zaoui P
J Nephrol; 2012; 25(4):558-65. PubMed ID: 22101677
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of the PAIR (Pharmacotherapy Assessment in Chronic Renal Disease) criteria to assess medication safety and use issues in patients with CKD.
Desrochers JF; Lemieux JP; Morin-Bélanger C; Paradis FS; Lord A; Bell R; Berbiche D; Bárcena PQ; Séguin NC; Desforges K; Legris MÈ; Sauvé P; Lalonde L
Am J Kidney Dis; 2011 Oct; 58(4):527-35. PubMed ID: 21778005
[TBL] [Abstract][Full Text] [Related]
4. Assessment for chronic kidney disease service in high-risk patients at community health clinics.
Patel HR; Pruchnicki MC; Hall LE
Ann Pharmacother; 2005 Jan; 39(1):22-7. PubMed ID: 15546945
[TBL] [Abstract][Full Text] [Related]
5. Implementation of a pharmacist medication review clinic for haemodialysis patients.
Mirkov S
N Z Med J; 2009 Jun; 122(1297):25-37. PubMed ID: 19648999
[TBL] [Abstract][Full Text] [Related]
6. In-hospital medication reviews reduce unidentified drug-related problems.
Bondesson A; Eriksson T; Kragh A; Holmdahl L; Midlöv P; Höglund P
Eur J Clin Pharmacol; 2013 Mar; 69(3):647-55. PubMed ID: 22955893
[TBL] [Abstract][Full Text] [Related]
7. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
8. Polypharmacy and medication-related complications in the chronic kidney disease patient.
Mason NA
Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):492-7. PubMed ID: 21788893
[TBL] [Abstract][Full Text] [Related]
9. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
[TBL] [Abstract][Full Text] [Related]
10. Interview of patients by pharmacists contributes significantly to the identification of drug-related problems (DRPs).
Viktil KK; Blix HS; Moger TA; Reikvam A
Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):667-74. PubMed ID: 16598835
[TBL] [Abstract][Full Text] [Related]
11. Drug related problems identified by European community pharmacists in patients discharged from hospital.
Paulino EI; Bouvy ML; Gastelurrutia MA; Guerreiro M; Buurma H;
Pharm World Sci; 2004 Dec; 26(6):353-60. PubMed ID: 15683106
[TBL] [Abstract][Full Text] [Related]
12. Medication-related problems in patients referred to aged care and memory clinics at a tertiary care hospital.
Elliott RA; Woodward MC
Australas J Ageing; 2011 Sep; 30(3):124-9. PubMed ID: 21923705
[TBL] [Abstract][Full Text] [Related]
13. Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study.
Pai AB; Boyd A; Depczynski J; Chavez IM; Khan N; Manley H
Pharmacotherapy; 2009 Dec; 29(12):1433-40. PubMed ID: 19947803
[TBL] [Abstract][Full Text] [Related]
14. Impact of collaborative pharmaceutical care on in-patients' medication safety: study protocol for a stepped wedge cluster randomized trial (MEDREV study).
Leguelinel-Blache G; Castelli C; Roux-Marson C; Bouvet S; Andrieu S; Cestac P; Collomp R; Landais P; Loulière B; Mouchoux C; Varin R; Allenet B; ; Bedouch P; Kinowski JM
Trials; 2018 Jan; 19(1):19. PubMed ID: 29310711
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and Management of Drug-Related Problems in Chronic Kidney Disease Patients by Severity Level: A Subanalysis of a Cluster Randomized Controlled Trial in Community Pharmacies.
Quintana-Bárcena P; Lord A; Lizotte A; Berbiche D; Lalonde L
J Manag Care Spec Pharm; 2018 Feb; 24(2):173-181. PubMed ID: 29384023
[TBL] [Abstract][Full Text] [Related]
16. [Pharmaceutical care in a visceral surgical ward].
Schneider R; Ranft D; Heinitz K; Uhlmann D; Hauss J; Frontini R; Leinung S
Zentralbl Chir; 2012 Apr; 137(2):173-9. PubMed ID: 21766274
[TBL] [Abstract][Full Text] [Related]
17. Strategies to reduce the risk of iatrogenic illness in complex older adults.
Onder G; van der Cammen TJ; Petrovic M; Somers A; Rajkumar C
Age Ageing; 2013 May; 42(3):284-91. PubMed ID: 23537588
[TBL] [Abstract][Full Text] [Related]
18. Assessment of clinical pharmacists' interventions in French hospitals: results of a multicenter study.
Bedouch P; Charpiat B; Conort O; Rose FX; Escofier L; Juste M; Roubille R; Allenet B
Ann Pharmacother; 2008 Jul; 42(7):1095-103. PubMed ID: 18559955
[TBL] [Abstract][Full Text] [Related]
19. Kidney disease health literacy among new patients referred to a nephrology outpatient clinic.
Burke MT; Kapojos J; Sammartino C; Gray NA
Intern Med J; 2014 Nov; 44(11):1080-6. PubMed ID: 24989694
[TBL] [Abstract][Full Text] [Related]
20. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
